{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:06Z","timestamp":1784139246254,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/sc.2012.174","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T10:21:07Z","timestamp":1358850067000},"page":"419-423","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity"],"prefix":"10.1038","volume":"51","author":[{"given":"M","family":"St\u00f6hrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"M\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Warnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Primus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Jinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Manu-Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Calomfirescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Strugala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"BFsc2012174_CR1","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0022-5347(17)45940-4","volume":"135","author":"JB Gajewski","year":"1986","unstructured":"Gajewski JB, Awad SA . Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. J Urol 1986; 135: 966\u2013968.","journal-title":"J Urol"},{"key":"BFsc2012174_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1464-410X.1995.tb07264.x","volume":"75","author":"H Madersbacher","year":"1995","unstructured":"Madersbacher H, St\u00f6hrer M, Richter R, Burgd\u00f6rfer H, Hachen HJ, M\u00fcrtz G . Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyperreflexia. Br J Urol 1995; 75: 452\u2013456.","journal-title":"Br J Urol"},{"key":"BFsc2012174_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2006.03.016","volume":"52","author":"M St\u00f6hrer","year":"2007","unstructured":"St\u00f6hrer M, M\u00fcrtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ et al Propiverine compared to oxybutynin in neurogenic detrusor overactivity \u2013 results of a randomized double-blind, multicenter study. Eur Urol 2007; 52: 235\u2013242.","journal-title":"Eur Urol"},{"key":"BFsc2012174_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/sj.sc.3100750","volume":"37","author":"M St\u00f6hrer","year":"1999","unstructured":"St\u00f6hrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K . Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia - a double-blind, placebo-controlled clinical trial. Spinal Cord 1999; 37: 196\u2013200.","journal-title":"Spinal Cord"},{"key":"BFsc2012174_CR5","first-page":"138","volume":"47","author":"M St\u00f6hrer","year":"1991","unstructured":"St\u00f6hrer M, Bauer P, Giannetti BM, Richter R, Burgd\u00f6rfer H, M\u00fcrtz G . Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial. Urol Int 1991; 47: 138\u2013143.","journal-title":"A multicentre placebo-controlled double-blind trial. Urol Int"},{"key":"BFsc2012174_CR6","unstructured":"Pannek J, St\u00f6hrer M, Blok B, Castro-Diaz D, Del Popolo G, Kramer G et al Guidelines on neurogenic lower urinary tract dysfunction. European Association of Urology 2011 pp 1\u201364."},{"key":"BFsc2012174_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2165\/00003495-200464080-00011","volume":"64","author":"MA Siddiqui","year":"2004","unstructured":"Siddiqui MA, Perry CM, Scott LJ . Oxybutynin extended release: a review of its use in the management of overactive bladder. Drugs 2004; 64: 885\u2013912.","journal-title":"Drugs"},{"key":"BFsc2012174_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2165\/00003088-200140030-00006","volume":"40","author":"B Olsson","year":"2001","unstructured":"Olsson B, Szamosi J . Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine. Clin Pharmacokinet 2001; 40: 227\u2013235.","journal-title":"Clin Pharmacokinet"},{"key":"BFsc2012174_CR9","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0022-5347(05)68810-6","volume":"161","author":"RU Anderson","year":"1999","unstructured":"Anderson RU, Mobley D, Blank B, Saltzstein D, Susset J, Brown JS . Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. J Urol 1999; 161: 1809\u20131812.","journal-title":"J Urol"},{"key":"BFsc2012174_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000096338","volume":"77","author":"KP J\u00fcnemann","year":"2006","unstructured":"J\u00fcnemann KP, Hessd\u00f6rfer E, Unamba-Oparah I, Berse M, Br\u00fcnjes R, Madersbacher H et al Propiverine hydrochloride immediate and extended release: comparison of efficacy and tolerability in patients with overactive bladder. Urol Int 2006; 77: 334\u2013339.","journal-title":"Urol Int"},{"key":"BFsc2012174_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","volume":"57","author":"P Van Kerrebroeck","year":"2001","unstructured":"Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A et al Tolterodine once-daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology 2001; 57: 414\u2013421.","journal-title":"Urology"},{"key":"BFsc2012174_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.urology.2007.11.008","volume":"71","author":"R Dmochowski","year":"2008","unstructured":"Dmochowski R, Sand P, Zinner N, Staskin D . Trospium chloride once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. Urology 2008; 71: 449\u2013454.","journal-title":"Urology"},{"key":"BFsc2012174_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0091270008315314","volume":"48","author":"K May","year":"2008","unstructured":"May K, Westphal K, Giessmann T, Wegner D, Adam U, Lerch MM et al Disposition and antimuscarinic effects of the urinary bladder spasmolytics propiverine: influence of dosage forms and circadian-time rhythms. J Clin Pharm 2008; 48: 570\u2013579.","journal-title":"J Clin Pharm"},{"key":"BFsc2012174_CR14","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1080\/03639040902882256","volume":"35","author":"J Ploen","year":"2009","unstructured":"Ploen J, Andersch J, Heschel M, Leopold S . Citric acid as pH-modifying additive in an extended releasepellet formulation containing a weakly basic drug. Drug Dev Ind Pharm 2009; 35: 1210\u20131218.","journal-title":"Drug Dev Ind Pharm"},{"key":"BFsc2012174_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U","volume":"18","author":"M St\u00f6hrer","year":"1999","unstructured":"St\u00f6hrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R et al The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 1999; 18: 139\u2013158.","journal-title":"Neurourol Urodyn"},{"key":"BFsc2012174_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167\u2013178.","journal-title":"Neurourol Urodyn"},{"key":"BFsc2012174_CR17","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/S0022-5347(01)65554-X","volume":"156","author":"T Yokota","year":"1996","unstructured":"Yokota T, Yamaguchi O . Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit. J Urol 1996; 156: 1862\u20131866.","journal-title":"J Urol"},{"key":"BFsc2012174_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/sj.bjp.0706244","volume":"145","author":"M Wuest","year":"2005","unstructured":"Wuest M, Hecht J, Christ T, Braeter M, Schoeberl C, Hakenberg OW et al Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. Br J Pharmacol 2005; 145: 608\u2013619.","journal-title":"Br J Pharmacol"},{"key":"BFsc2012174_CR19","first-page":"S140","volume":"11","author":"S Varadharajan","year":"2005","unstructured":"Varadharajan S, Jumadilova Z, Girase P, Ollendorf D . Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder. Am J Managed Care 2005; 11: S140\u2013S149.","journal-title":"Am J Managed Care"},{"key":"BFsc2012174_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.18553\/jmcp.2008.14.3.291","volume":"14","author":"A D'Souza","year":"2008","unstructured":"D'Souza A, Smith M, Miller L-A, Doyle J, Ariely R . Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Managed Care Pharm 2008; 14: 291\u2013301.","journal-title":"J Managed Care Pharm"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sc2012174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc2012174","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc2012174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:23:00Z","timestamp":1684621380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sc2012174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFsc2012174"],"URL":"https:\/\/doi.org\/10.1038\/sc.2012.174","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}